| Network analysis of EMT and MET micro-RNA regulation in breast cancer D Drago-García, J Espinal-Enríquez, E Hernández-Lemus Scientific reports 7 (1), 13534, 2017 | 45 | 2017 |
| AXL and error-prone DNA replication confer drug resistance and offer strategies to treat EGFR-mutant lung cancer A Noronha, N Belugali Nataraj, JS Lee, B Zhitomirsky, Y Oren, S Oster, ... Cancer discovery 12 (11), 2666-2683, 2022 | 39 | 2022 |
| Targeting HER3, a catalytically defective receptor tyrosine kinase, prevents resistance of lung cancer to a third-generation EGFR kinase inhibitor D Romaniello, I Marrocco, N Belugali Nataraj, I Ferrer, D Drago-Garcia, ... Cancers 12 (9), 2394, 2020 | 34 | 2020 |
| PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR S Ghosh, NB Nataraj, A Noronha, S Patkar, A Sekar, S Mukherjee, ... Cell reports 35 (8), 2021 | 28 | 2021 |
| Nonredundant, highly connected microRNAs control functionality in breast cancer networks G de Anda-Jáuregui, J Espinal-Enríquez, D Drago-García, ... International journal of genomics 2018, 2018 | 26 | 2018 |
| ETS proteins bind with glucocorticoid receptors: Relevance for treatment of Ewing sarcoma S Srivastava, NB Nataraj, A Sekar, S Ghosh, C Bornstein, D Drago-Garcia, ... Cell Reports 29 (1), 104-117. e4, 2019 | 18 | 2019 |
| Reduced lamin A/C does not facilitate cancer cell transendothelial migration but compromises lung metastasis F Roncato, O Regev, SW Feigelson, SK Yadav, L Kaczmarczyk, N Levi, ... Cancers 13 (10), 2383, 2021 | 16 | 2021 |
| Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors NB Nataraj, A Noronha, JS Lee, S Ghosh, HRM Raju, A Sekar, ... Cell reports 38 (8), 2022 | 14 | 2022 |
| Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models I Marrocco, D Romaniello, I Vaknin, D Drago‐Garcia, R Oren, ML Uribe, ... EMBO Molecular Medicine 13 (4), e13144, 2021 | 13 | 2021 |
| TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasis ML Uribe, M Dahlhoff, RN Batra, NB Nataraj, Y Haga, D Drago-Garcia, ... Science signaling 14 (688), eabe6156, 2021 | 9 | 2021 |
| Targeting autocrine amphiregulin robustly and reproducibly inhibits ovarian cancer in a syngeneic model: roles for wildtype p53 M Lindzen, S Ghosh, A Noronha, D Drago, NB Nataraj, O Leitner, ... Oncogene 40 (21), 3665-3679, 2021 | 9 | 2021 |
| Host-dependent phenotypic resistance to EGFR tyrosine kinase inhibitors Y Haga, I Marrocco, A Noronha, ML Uribe, NB Nataraj, A Sekar, ... Cancer research 81 (14), 3862-3875, 2021 | 4 | 2021 |
| Targeting HER3, a Catalytically Defective Receptor Tyros‑ine Kinase, Prevents Resistance of Lung Cancer to a Third‑Generation EGFR Kinase Inhibitor. Cancers (Basel). 2020; 12 (9) D Romaniello, I Marrocco, N Belugali Nataraj, I Ferrer, D Drago-Garcia, ... | 3 | |
Ilaria MarroccoSenior Posdoc, Weizmann Institute of scienceVerified email at weizmann.ac.il
